Lycopodium Limited
LYOPF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.19 | 0.26 | -0.15 | 0.27 |
| FCF Yield | 3.45% | 3.69% | 4.49% | 2.05% |
| EV / EBITDA | 12.43 | 13.04 | 10.10 | 7.38 |
| Quality | ||||
| ROIC | 1.59% | 21.94% | 13.05% | 20.98% |
| Gross Margin | 152.76% | 30.73% | 20.80% | 25.54% |
| Cash Conversion Ratio | -0.65 | 0.83 | 0.85 | 0.26 |
| Growth | ||||
| Revenue 3-Year CAGR | 22.99% | 24.03% | 23.15% | 20.14% |
| Free Cash Flow Growth | -25.18% | 19.16% | 124.14% | 22.51% |
| Safety | ||||
| Net Debt / EBITDA | -2.08 | -1.45 | -1.73 | -1.24 |
| Interest Coverage | 10.43 | 0.00 | 76.24 | 90.27 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 420.28 | 1,360.96 |
| Cash Conversion Cycle | 66.39 | 20.81 | 25.27 | 26.96 |